Cristina Monica Puiu, PT | |
285 Sills Rd Bldg 18, East Patchogue, NY 11772-4808 | |
(631) 475-1224 | |
(631) 475-1588 |
Full Name | Cristina Monica Puiu |
---|---|
Gender | Female |
Speciality | Physical Therapist |
Location | 285 Sills Rd Bldg 18, East Patchogue, New York |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366169310 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 021100 (New York) | Primary |
Provider Name | New York University |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20081202000185 |
News Archive
COPAN, an innovative company focused on bringing breakthrough products to Microbiology preanalytics around the world, announced that it has obtained FDA clearance for its new FecalSwab.
Treatment with dexpramipexole - a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell's energy - appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Promising results of a phase 2 trial of dexpramipexole are receiving advance online publication in Nature Medicine.
Amgen today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended a positive opinion for the marketing authorization of XGEVA (denosumab) for the prevention of skeletal-related events (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with bone metastases from solid tumors.
A report by federal health care inspectors in November said the U.S. nursing home industry overbills Medicare $1.5 billion a year for treatments patients don't need or never receive.
› Verified 5 days ago
Provider Name | New York University |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
COPAN, an innovative company focused on bringing breakthrough products to Microbiology preanalytics around the world, announced that it has obtained FDA clearance for its new FecalSwab.
Treatment with dexpramipexole - a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell's energy - appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Promising results of a phase 2 trial of dexpramipexole are receiving advance online publication in Nature Medicine.
Amgen today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended a positive opinion for the marketing authorization of XGEVA (denosumab) for the prevention of skeletal-related events (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with bone metastases from solid tumors.
A report by federal health care inspectors in November said the U.S. nursing home industry overbills Medicare $1.5 billion a year for treatments patients don't need or never receive.
› Verified 5 days ago
Provider Name | Orthopedic Assoc Of Long Island Physicians & Medical Group Pllc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1225593809 PECOS PAC ID: 6204169147 Enrollment ID: O20190610001136 |
News Archive
COPAN, an innovative company focused on bringing breakthrough products to Microbiology preanalytics around the world, announced that it has obtained FDA clearance for its new FecalSwab.
Treatment with dexpramipexole - a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell's energy - appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Promising results of a phase 2 trial of dexpramipexole are receiving advance online publication in Nature Medicine.
Amgen today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended a positive opinion for the marketing authorization of XGEVA (denosumab) for the prevention of skeletal-related events (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with bone metastases from solid tumors.
A report by federal health care inspectors in November said the U.S. nursing home industry overbills Medicare $1.5 billion a year for treatments patients don't need or never receive.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Cristina Monica Puiu, PT 285 Sills Rd Bldg 18, East Patchogue, NY 11772-4808 Ph: (631) 475-1224 | Cristina Monica Puiu, PT 285 Sills Rd Bldg 18, East Patchogue, NY 11772-4808 Ph: (631) 475-1224 |
News Archive
COPAN, an innovative company focused on bringing breakthrough products to Microbiology preanalytics around the world, announced that it has obtained FDA clearance for its new FecalSwab.
Treatment with dexpramipexole - a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell's energy - appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Promising results of a phase 2 trial of dexpramipexole are receiving advance online publication in Nature Medicine.
Amgen today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended a positive opinion for the marketing authorization of XGEVA (denosumab) for the prevention of skeletal-related events (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with bone metastases from solid tumors.
A report by federal health care inspectors in November said the U.S. nursing home industry overbills Medicare $1.5 billion a year for treatments patients don't need or never receive.
› Verified 5 days ago
Jennifer Fryant, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 191 Patchogue Yaphank Rd, East Patchogue, NY 11772 Phone: 631-775-0971 Fax: 631-475-0975 | |
Dr. Craig M Zeier, PT, DPT, MS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 100 Hospital Rd Ste 112, East Patchogue, NY 11772 Phone: 631-456-5512 Fax: 631-456-5514 | |
Brooks Comeno, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 191 Patchogue Yaphank Rd, East Patchogue, NY 11772 Phone: 631-775-0971 | |
Kathryn Hoffmann, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 100 Hospital Rd, Suite 112, East Patchogue, NY 11772 Phone: 631-456-5512 Fax: 631-456-5514 | |
James Vito Maone, PT Physical Therapist Medicare: May Accept Medicare Assignments Practice Location: 21 Durkee Ln, East Patchogue, NY 11772 Phone: 631-790-1700 | |
Colin Homola, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 191 Patchogue Yaphank Rd, East Patchogue, NY 11772 Phone: 631-775-0971 Fax: 631-475-0975 | |
Angela Julienne Fernandez Lam, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 285 Sills Rd Bldg 5-6, East Patchogue, NY 11772 Phone: 631-475-2858 Fax: 631-475-2886 |